YTHDF2 and leukemia: YTHDF2, overexpressed in human AML samples, is considered to facilitate leukemia initiation and LSC maintenance by shortening the half-life of various m6A transcripts in favor of LSC functions and regulating mRNA decay in an m6A-dependent way.